ROR1-IN-4
ROR1-IN-4 is a selective ROR1 inhibitor with a Kd of 52 nM. ROR1-IN-4 shows potent anti-proliferative activity against TNBC cell line MDA-MB-231 (IC50 = 75 nM). ROR1-IN-4 reduces colony formation, induces apoptosis and inhibits the phosphorylation of ROR1 (Tyr786) in MDA-MB-231 cells. ROR1-IN-4 demonstrates superior anti-tumor efficacy in nude mice bearing MDA-MB-231 subcutaneous xenografts. ROR1-IN-4 can be used for the study of triple-negative breast cancer (TNBC).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C29H30F2N6O
- 分子量:516.58
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
|
ROR1 0.052 μM (Kd) |
ROR1-IN-4 (Compound 59) (72 h) shows potent anti-proliferative activity against TNBC cell line MDA-MB-231 (IC50 = 0.075 μM), and no significant anti-proliferative activity against non-TNBC cell line MCF-7 (IC50 > 10 μM) and HEK-293T (IC50 = 9.72 μM)[1].
ROR1-IN-4 (0.1-3 μM, 48 h) induces apoptosis and inhibits the phosphorylation of ROR1 (Tyr786) in MDA-MB-231 cells[1].
ROR1-IN-4 (0.1-1 μM, 14 days) reduces colony formation in MDA-MB-231 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MDA-MB-231 cells
-
Concentration:0.1, 0.3, 1 μM
-
Incubation Time:48 h
-
Result:Induced apoptosis in MDA-MB-231 cells.
Reduced the expression of anti-apoptotic protein Bcl-2.
Increased the expression of pro-apoptotic protein Bax, and promotes the cleavage of PARP in a concentration-dependent manner.
ROR1-IN-4 (10 mg/kg, i.p, every other day, 45 days) exerts potent anti-tumor growth and anti-metastasis effects in nude mice with MDA-MB-231-Luc orthotopic breast xenografts[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:MDA-MB-231 cells (5 × 106 in 100 µL mixture of PBS and Matrigel at 1:1 ratio) were subcutaneously implanted into the flanks of 4-5-week-old female BALB/c nude mice to establish the subcutaneous TNBC xenograft model[1]
-
Dosage:10, 20 mg/kg
-
Administration:i.p. every other day for 30 days
-
Result:Achieved tumor growth inhibition (TGI) rates of 62.1% and 92.1% at doses of 10 mg/kg and 20 mg/kg, respectively.
Showed no significant decrease in body weight of nude mice during the 30-day administration period.
Led to no significant histopathological changes in major organs (heart, liver, spleen, lung, kidney) of nude mice.
Resulted in no increase in tumor size of nude mice in the 20 mg/kg dose group throughout the entire administration period.
-
Animal Model:MDA-MB-231-Luc cells (3 × 106) were orthotopically implanted into the mammary fat pads of 4-5-week-old female BALB/c nude mice to establish the orthotopic breast TNBC xenograft model[1]
-
Dosage:10 mg/kg
-
Administration:i.p. every other day for 45 days
-
Result:Significantly reduced the size of orthotopic breast tumors in nude mice.
Inhibited tumor metastasis effectively: no tumor metastasis was found in nude mice at the 45th day of treatment.
Caused no obvious pathological changes in the heart and kidneys of nude mice; only mild inflammatory cell infiltration was observed in the liver, and the degree of spleen lesions and tumor cell invasion was lower than that in the vehicle group.
Delayed the occurrence of mouse death.
Showed no significant abnormal changes in the body weight.
化学情報
-
分子量 516.58
-
分子式 C29H30F2N6O
-
SMILES
FC(C1=CC(NC(C2=CC=C(C(C3=CC=C4N=C(N=CC4=C3)N)=C2)C)=O)=CC=C1CN5CCN(CC5)C)F
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
ROR1-IN-4 関連分類
HY-175497 関連分類
Powered by Bioz